This case discusses the issue of the proposed National Pharmaceutical Policy, 2006, the new drug price control policy in India. The pharma industry wants competition-based price monitoring instead of cost-based price control. However, the government is keen to add another 354 drugs to the list of drugs under price control
Notes
Title from resource description page (viewed June 17, 2016)
